Yijia Li

3.2k total citations
70 papers, 623 citations indexed

About

Yijia Li is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Yijia Li has authored 70 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 18 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Yijia Li's work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (16 papers) and HIV/AIDS Research and Interventions (14 papers). Yijia Li is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (16 papers) and HIV/AIDS Research and Interventions (14 papers). Yijia Li collaborates with scholars based in China, United States and Canada. Yijia Li's co-authors include Jonathan Z. Li, Taisheng Li, Ronald J. Bosch, Yang Han, Jing Xie, Xiaojing Song, Yanling Li, Wei Lv, Jean‐Pierre Routy and Huanling Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yijia Li

63 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yijia Li China 13 350 186 131 68 67 70 623
Opass Putcharoen Thailand 13 429 1.2× 100 0.5× 119 0.9× 25 0.4× 41 0.6× 47 546
Xien Gui China 13 361 1.0× 116 0.6× 235 1.8× 35 0.5× 23 0.3× 46 618
Björn‐Erik Ole Jensen Germany 18 316 0.9× 157 0.8× 138 1.1× 16 0.2× 72 1.1× 75 774
Jingna Xun China 13 484 1.4× 71 0.4× 108 0.8× 27 0.4× 168 2.5× 33 738
Alaka Deshpande India 14 387 1.1× 333 1.8× 210 1.6× 10 0.1× 44 0.7× 52 702
Guiju Gao China 12 770 2.2× 70 0.4× 200 1.5× 118 1.7× 96 1.4× 40 1.0k
Pierre de Truchis France 13 259 0.7× 148 0.8× 181 1.4× 21 0.3× 77 1.1× 50 644
Daryl S. Schiller United States 10 190 0.5× 200 1.1× 130 1.0× 21 0.3× 69 1.0× 16 470
Hammer Sm United States 15 318 0.9× 277 1.5× 112 0.9× 9 0.1× 39 0.6× 27 542
Patricia Cane United Kingdom 19 538 1.5× 402 2.2× 414 3.2× 64 0.9× 51 0.8× 27 1.1k

Countries citing papers authored by Yijia Li

Since Specialization
Citations

This map shows the geographic impact of Yijia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yijia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yijia Li more than expected).

Fields of papers citing papers by Yijia Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yijia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yijia Li. The network helps show where Yijia Li may publish in the future.

Co-authorship network of co-authors of Yijia Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yijia Li. A scholar is included among the top collaborators of Yijia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yijia Li. Yijia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yijia, Mounia Alaoui-El-Azher, Paolo Piazza, et al.. (2025). Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence. AIDS. 39(9). 1120–1124. 2 indexed citations
2.
Wei, Kung‐Hwa, Xabier Rodríguez‐Martínez, Leonidas Tsetseris, et al.. (2025). Novel ambipolar polymers for detection beyond 1000 nm with organic phototransistors. Materials Horizons. 13(1). 464–472.
3.
Jin, Qiao, Fangyuan Chen, Yiliang Zhou, et al.. (2024). Hidden flaws behind expert-level accuracy of multimodal GPT-4 vision in medicine. npj Digital Medicine. 7(1). 190–190. 47 indexed citations
4.
Zhou, Shuntai, Nathan Long, Collin S Hill, et al.. (2024). Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes. The Journal of Infectious Diseases. 230(1). 86–94. 1 indexed citations
7.
Li, Yijia, Madhu Choudhary, & John W. Mellors. (2024). The Current Pipeline of Antiretroviral Therapy. Infectious Disease Clinics of North America. 38(3). 395–408. 2 indexed citations
8.
Etemad, Behzad, Christy L. Lavine, Yijia Li, et al.. (2023). Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption. Science Translational Medicine. 15(695). eabq4490–eabq4490. 12 indexed citations
9.
Meyerowitz, Eric A. & Yijia Li. (2023). Review: The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses. Clinical Infectious Diseases. 78(4). 908–917. 12 indexed citations
10.
Castanha, Priscila M. S., Mounia Alaoui-El-Azher, Jishnu Das, et al.. (2023). SARS-CoV-2 mRNA Vaccines Induce Greater Complement Activation and Decreased Viremia and Nef Antibodies in Men With HIV-1. The Journal of Infectious Diseases. 229(4). 1147–1157.
11.
Wang, Chuangqi, Yijia Li, Paulina Kapłonek, et al.. (2022). The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia. mBio. 13(4). e0157722–e0157722. 9 indexed citations
12.
Torres, Jonathan L., Yijia Li, Alex Van Ry, et al.. (2021). One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization. Emerging Microbes & Infections. 10(1). 2016–2029. 12 indexed citations
13.
Li, Yijia, et al.. (2020). Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical Studies. SHILAP Revista de lepidopterología. 11 indexed citations
14.
Li, Yijia, James Regan, Jesse Fajnzylber, et al.. (2020). Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19. Hepatology Communications. 5(3). 434–445. 40 indexed citations
15.
Li, Yijia, Susan E. Stanley, Julian A. Villalba, Sandra B. Nelson, & Jeffrey A. Gelfand. (2020). Case Report: Overwhelming Babesia Parasitemia Successfully Treated Promptly With RBC Apheresis and Triple Therapy With Clindamycin, Azithromycin, and Atovaquone. Open Forum Infectious Diseases. 7(10). ofaa448–ofaa448. 7 indexed citations
16.
Li, Yijia, Jing Xie, Yang Han, et al.. (2016). Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects. Medicine. 95(5). e2660–e2660. 9 indexed citations
17.
Han, Yang, Yijia Li, Jing Xie, et al.. (2015). Week 120 Efficacy of Tenofovir, Lamivudine and Lopinavir/r-Based Second-Line Antiretroviral Therapy in Treatment-Experienced HIV Patients. PLoS ONE. 10(3). e0120705–e0120705. 6 indexed citations
18.
Li, Yijia. (2014). Antimicrobial and Preservative Effects of Natamycin on Ginkgo Fruits. Food Science. 2 indexed citations
19.
Wang, Chen, Yijia Li, & Ji-Min Cao. (2013). Specificity out of clutter: A hypothetical role of G protein‐coupled receptors in the non‐genomic effect of steroids. FEBS Letters. 587(7). 823–825. 3 indexed citations
20.
Li, Yijia, et al.. (2000). Detection of a human parvovirus intrauterine infection with the polymerase chain reaction.. PubMed. 45(5). 410–2. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026